STAT3 and cancer: STAT3 has been extensively studied as a therapeutic target in cancers, and STAT3 inhibitors or drugs have been greatly progressed.[27, 28] Two major solutions including targeting upstream regulators and blocking phosphorylation, dimerization, nuclear translocation, and DNA binding[27, 28, 29] have been extensively studied.